These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 31666026)

  • 1. Postoperative chemoradiotherapy is superior to postoperative chemotherapy alone in squamous cell lung cancer patients with limited N2 lymph node metastasis.
    Su L; Chen M; Su H; Dai Y; Chen S; Li J
    BMC Cancer; 2019 Oct; 19(1):1023. PubMed ID: 31666026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of adjuvant chemoradiotherapy on survival after R0 resection for stage III-N2 nonsmall cell lung cancer: A meta-analysis.
    Li D; Li W; Pang Y; Xu L; Xu X
    Medicine (Baltimore); 2022 Jul; 101(28):e29580. PubMed ID: 35839033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of efficacy for postoperative chemotherapy and concurrent radiochemotherapy in patients with IIIA-pN2 non-small cell lung cancer: an early closed randomized controlled trial.
    Shen WY; Ji J; Zuo YS; Pu J; Xu YM; Zong CD; Tao GZ; Chen XF; Ji FZ; Zhou XL; Han JH; Wang CS; Yi JG; Su XL; Zhu WG
    Radiother Oncol; 2014 Jan; 110(1):120-5. PubMed ID: 24183868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 5. A multicenter retrospective analysis of survival outcome following postoperative chemoradiotherapy in non-small-cell lung cancer patients with N2 nodal disease.
    Zou B; Xu Y; Li T; Li W; Tang B; Zhou L; Li L; Liu Y; Zhu J; Huang M; Wang J; Ren L; Gong Y; Che G; Liu L; Hou M; Lu Y
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):321-8. PubMed ID: 19775829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the fate of patients who undergo resections of very large, node-negative lung cancers using the National Cancer DataBase.
    Liu J; Hancock JG; Moreno AC; Wang Z; Boffa DJ; Detterbeck FC; Kim AW
    Eur J Cardiothorac Surg; 2016 Feb; 49(2):596-601. PubMed ID: 25890936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical therapeutic strategy for non-small cell lung cancer with (N2) mediastinal lymph node metastasis].
    Huang GJ; Fang DK; Cheng GY; Zhang DC
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):62-4. PubMed ID: 16737625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymph node status and histologic subtypes influenced the effect of postoperative radiotherapy on patients with N2 positive IIIA non-small cell lung cancer.
    Yuan C; Tao X; Zheng D; Pan Y; Ye T; Hu H; Xiang J; Zhang Y; Chen H; Sun Y
    J Surg Oncol; 2019 Mar; 119(3):379-387. PubMed ID: 30536966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skip mediastinal lymph node metastasis and lung cancer: a particular N2 subgroup with a better prognosis.
    Riquet M; Assouad J; Bagan P; Foucault C; Le Pimpec Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2005 Jan; 79(1):225-33. PubMed ID: 15620948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal Up-Staging During Surgery in Non-Small-Cell Lung Cancer: Which Mediastinal Lymph Node Metastasis Patterns Better Predict The Outcome? A Multicenter Analysis.
    Chiappetta M; Leuzzi G; Sperduti I; Bria E; Mucilli F; Lococo F; Filosso PL; Ratto GB; Spaggiari L; Facciolo F
    Clin Lung Cancer; 2020 Sep; 21(5):464-471.e1. PubMed ID: 32389508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases].
    Zhang GQ; Han F; Gao SL; A DL; Pang ZL
    Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of predictive factors for postoperative survival for non small cell lung carcinoma patients with unexpected mediastinal lymph nodes metastasis.
    Wang S; Zhou W; Zhang H; Zhao M; Chen X
    Thorac Cardiovasc Surg; 2014 Mar; 62(2):126-32. PubMed ID: 23585223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis of 220 patients with completely resected stage-II non-small cell lung cancer.
    Dai Y; Su XD; Long H; Lin P; Fu JH; Zhang LJ; Wang X; Wen ZS; Zhu ZH; Zhang X; Rong TH
    Chin J Cancer; 2010 May; 29(5):538-44. PubMed ID: 20426905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
    Qiu C; Dong W; Su B; Liu Q; Du J
    J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical therapeutic strategy for non-small cell lung cancer with mediastinal lymph node metastasis (N2).
    Ma Q; Liu D; Guo Y; Shi B; Song Z; Tian Y
    Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):342-8. PubMed ID: 20677562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of postoperative radiation for stage IIIA pathologic N2 non-small cell lung cancer: impact of metastatic lymph node number.
    Wang S; Ma Z; Yang X; Wang Y; Xu Y; Xia W; Chen R; Qiu M; Jiang F; Yin R; Xu L; Xu K
    Radiat Oncol; 2017 Dec; 12(1):207. PubMed ID: 29284511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes and prognostic factors of non-small-cell lung cancer with lymph node involvement treated with induction treatment and surgical resection.
    Marulli G; Verderi E; Zuin A; Schiavon M; Battistella L; Perissinotto E; Romanello P; Favaretto AG; Pasello G; Rea F
    Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):256-62; discussion 262. PubMed ID: 24824495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].
    Liu K; Chen HL; You QS; Huang JF; Wang H
    Ai Zheng; 2009 Jul; 28(7):725-9. PubMed ID: 19624899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival benefit of skip metastases in surgically resected N2 non-small cell lung cancer: A multicenter observational study of a large cohort of the Chinese patients.
    Li X; Li X; Fu X; Liu L; Liu Y; Zhao H; Li Y; Hu J; Xu L; Liu D; Yang H; Zhang X
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1874-1881. PubMed ID: 31902592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term survival after complete mediastinal lymph node resection and lobectomy in patients with bulky N2 non-small cell lung cancer.
    Sakuraba M; Takahashi N; Oh S; Miyasaka Y; Inagaki T; Suzuki K
    Ann Thorac Cardiovasc Surg; 2011; 17(2):124-9. PubMed ID: 21597408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.